Gestational trophoblastic disease (GTD)
- General Enquiries
- 020 3311 1234
The gestational trophoblastic disease (GTD) service at Charing Cross Hospital is a highly specialist service providing comprehensive registration, screening and clinical management for all forms of the disease.
Our internationally renowned GTD team are world leaders in the investigation and treatment of these rare conditions. Charing Cross Hospital is one of only two hospitals in the UK designated to treat GTD – registering around 1,200 women and treating around 120 women. We have a 100 per cent cure rate for patients identified through our registration and screening facility. Our service has the largest database of GTD patients in the world, holding records of over 35,000 women with the condition. This provides excellent data for research and audit, leading to excellent outcomes, improved treatment and better services for patients.
Conditions and treatments
GTD is a general term used to cover several diseases that occur during or following pregnancy. These include non-malignant (non-cancerous) partial and complete hydatidiform mole and the malignant (cancerous) invasive mole, as well as choriocarcinoma, and placental site trophoblastic tumour.
Most patients will not have heard of molar pregnancies, trophoblasts or choriocarcinoma, prior to their diagnosis, and finding reliable advice on the internet can be challenging.
Ninety per cent of women with GTD will not need to be seen at the hospital and will be monitored via the postal system with access to our advisory service for results and advice. In some cases, further treatment is required. Treatment for GTD is usually chemotherapy (drug treatment), but surgery is sometimes an option.
We welcome short and long term placements for visiting doctors both nationally and internationally who have an interest in GTD. Nurses with an interest in GTD are also welcome to visit. Please contact firstname.lastname@example.org.
Patient drop-in sessions
Bi-monthly patient drop-in sessions are held in February, April, June, August, October and December each year. Newly diagnosed patients are invited to attend the sessions, which are held at Charing Cross Hospital. For further information please contact the advisory team on 020 3311 1409.
Further online resources
- Molar Pregnancy
- Cancer Treatment and Research Trust – Charing Cross Hospital – the Cancer Treatment and Research Trust is a charitable fund set up to enable us to undertake research into the diseases we diagnose and treat. Visit this site for further information about how you can support our research.
- International Society for the Study of Trophoblastic Diseases (ISSTD) – the ISSTD is the official medical agency for physicians treating hydatidiform mole, PSTT, and choriocarcinoma. It holds biennial symposia for its members, for more information please visit their website.
- Sheffield Trophoblastic Disease Centre – the Sheffield Trophoblastic Disease Centre screens for gestational trophoblastic tumours and a spectrum of disorders including hydatidiform mole and choriocarcinoma.
- My Molar Pregnancy – information, personal stories, and support for women with molar pregnancy. This site is for women with molar pregnancy or who want to know more about it, without the medical jargon. Here you'll find the help and support you need.
- Miscarriage Association – the Miscarriage Association provides support and information for anyone affected by miscarriage, ectopic pregnancy or molar pregnancy.
- Cancer Research UK
Read the full story
Ultrasound scan can diagnose prostate cancer
An ultrasound scan can be used to detect cases of prostate cancer, according to new research by Imperial College London, University College London and Imperial College Healthcare NHS Trust. The study found that a new type of ultrasound scan can…
Read the full story
MRI tool that can diagnose difficult cases of ovarian cancer to be tested at the Trust
Imperial College Healthcare NHS Trust is going to be part of a major trial that will evaluate a new MRI tool for diagnosing ovarian cancer. The new tool can identify cases of ovarian cancer which are difficult to diagnose using standard methods and…
Read the full story
Pioneering software set to improve NHS imaging services across north west London
Imperial College Healthcare is one of six NHS trusts in north west London that have formed a new network to improve imaging services – including x-ray, MRI and CT scans – to enable better care for cancer, stroke and a wide range of other conditions.